Posted inLondon Stock Exchange
AstraZeneca agrees obesity and T2D deal with CSPC
LONDON: AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes…